📰 Immune Modulation News
Immune Modulation News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Immune Modulation. Real-time updates on events, politics, business and more.
February 16, 2024
PRINCETON, N.J. & TOKYO & WALTHAM, Mass.--(BUSINESS WIRE)--Feb 16, 2024--
February 16, 2024
PRINCETON, N.J. & TOKYO & WALTHAM, Mass.--(BUSINESS WIRE)--Otsuka Pharmaceutical Development & Commercialization, Inc., (OPDC); Otsuka Pharmaceutical, Co. Ltd. (Otsuka); and Visterra, Inc., an Otsuka group company announce that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designat...
November 29, 2023
TORONTO & WALTHAM, Mass.--(BUSINESS WIRE)--Nov 29, 2023--
October 3, 2023
In this sixth episode of OncChats: Leveraging Endoscopic Ultrasound in Pancreatic Cancer, Toufic A. Kachaamy, MD, Madappa Kundranda, MD, PhD, and Tamas A. Gonda, MD, briefly discuss pancreatic cancer ablation and immune modulation.
September 25, 2023
Clinical trial to evaluate the immune modulation approach for hospitalized COVID-19 patients kicks off to investigate the potential benefits of immune modulation.
July 7, 2023
Postdoc – Immune Modulation in Cancer and Microbiome (m/f/d) in Full time, Postdoctoral, Biomedicine with PWG Professional-Werbe-Gesellschaft mbH. Apply Today.
November 29, 2022
Biofit provides billions of CFUs of seven strains of probiotic bacteria that are good for weight loss goals. Here is our BioFit reviews 2023.
June 14, 2022
PROVIDENCE, R.I., June 11, 2022 /PRNewswire/ -- EpiVax, Inc. ("EpiVax") announces that it has developed VennVax, a smallpox vaccine candidate that is predicted to be highly effective against monkeypox. The development of this vaccine was funded by the National Institutes of Health (SBIR grant #R43AI058376). The company is looking for a strategic partner with funding and experience in advanced preclinical development and clinical trials to move this "Epitope-Driven Vaccine" in...
April 21, 2022
/PRNewswire/ -- The global advanced drug delivery systems market size is expected to increase by USD 91.79 billion between 2021 and 2026. Technavio expects the...
December 15, 2021
/PRNewswire/ - MYND Life Sciences Inc. ("MYND" or the "Company") (CSE: MYND) (OTC: MYNDF) is pleased to announce it has completed the National Phase filing of...